Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Mar;59(3):879–884. doi: 10.1128/iai.59.3.879-884.1991

Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.

P K Lee 1, J R Deringer 1, B N Kreiswirth 1, R P Novick 1, P M Schlievert 1
PMCID: PMC258342  PMID: 1997438

Abstract

Toxic shock syndrome toxin 1 (TSST-1) and streptococcal pyrogenic exotoxin A (SPE A) belong to a family of pyrogenic toxins produced by Staphylococcus aureus and Streptococcus pyogenes, respectively. Both toxins are responsible for causing toxic shock syndrome (TSS) and related illnesses, clinically characterized by multiorgan involvement. The most severe TSS symptom is acute hypotension and shock after the initial febrile response. In this study, we examined possible mechanisms of shock development in TSS, particularly the role of T-cell proliferation, endotoxin enhancement by toxins, and capillary leakage. American Dutch belted rabbits, with subcutaneously implanted miniosmotic pumps filled with either TSST-1 or SPE A, served as the animal model. For both TSST-1 and SPE A-treated rabbits, administration of cyclosporin A prevented toxin-induced T-cell proliferation but failed to protect the rabbits. Polymyxin B treatment of rabbits, to neutralize endogenous endotoxin, partially protected rabbits from challenge with either exotoxin; two of six rabbits survived on day 2 when treated with only TSST-1, whereas six of six animals survived after challenge with TSST-1 and polymyxin B. Similarly, with SPE A-treated rabbits, only 1 of 10 animals without polymyxin B treatment survived on day 8, but 4 of 6 rabbits survived on day 8 when given polymyxin B. Fluid replacement was successful in preventing lethality. Twelve of 14 rabbits survived when given TSST-1 with fluid, and all rabbits treated with SPE A and fluid survived. Finally, by using miniosmotic pumps, staphylococcal exfoliative toxin A and concanavalin A were administered to rabbits in an attempt to induce lethality. These two T-cell mitogens caused T-cell proliferation but failed to induce lethality in rabbits. The data suggest that toxin interactions causing vascular leakage and to some extent endotoxin enhancement are of major importance in development of hypotension and shock in TSS. It appears that T-cell proliferation may not contribute significantly to the induction of shock and death.

Full text

PDF
879

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsumian E. L., Schlievert P. M., Watson D. W. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun. 1978 Dec;22(3):681–688. doi: 10.1128/iai.22.3.681-688.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  3. Beutler B., Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655. doi: 10.1146/annurev.iy.07.040189.003205. [DOI] [PubMed] [Google Scholar]
  4. Blomster-Hautamaa D. A., Kreiswirth B. N., Novick R. P., Schlievert P. M. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing. Biochemistry. 1986 Jan 14;25(1):54–59. doi: 10.1021/bi00349a009. [DOI] [PubMed] [Google Scholar]
  5. Bulanda M., Zaleska M., Mandel L., Talafantova M., Travnicek J., Kunstmann G., Mauff G., Pulverer G., Heczko P. B. Toxicity of staphylococcal toxic shock syndrome toxin 1 for germ-free and conventional piglets. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S248–S253. doi: 10.1093/clinids/11.supplement_1.s248. [DOI] [PubMed] [Google Scholar]
  6. Chesney P. J. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S1–S7. [PubMed] [Google Scholar]
  7. Chow A. W., Wittmann B. K., Bartlett K. H., Scheifele D. W. Variant postpartum toxic shock syndrome with probable intrapartum transmission to the neonate. Am J Obstet Gynecol. 1984 Apr 15;148(8):1074–1079. doi: 10.1016/s0002-9378(84)90448-4. [DOI] [PubMed] [Google Scholar]
  8. Cone L. A., Woodard D. R., Schlievert P. M., Tomory G. S. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987 Jul 16;317(3):146–149. doi: 10.1056/NEJM198707163170305. [DOI] [PubMed] [Google Scholar]
  9. Crass B. A., Bergdoll M. S. Toxin involvement in toxic shock syndrome. J Infect Dis. 1986 May;153(5):918–926. doi: 10.1093/infdis/153.5.918. [DOI] [PubMed] [Google Scholar]
  10. Cunningham C. M., Watson D. W. Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response. Infect Immun. 1978 Jan;19(1):51–57. doi: 10.1128/iai.19.1.51-57.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fast D. J., Schlievert P. M., Nelson R. D. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol. 1988 Feb 1;140(3):949–953. [PubMed] [Google Scholar]
  12. Fast D. J., Schlievert P. M., Nelson R. D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun. 1989 Jan;57(1):291–294. doi: 10.1128/iai.57.1.291-294.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Igarashi H., Fujikawa H., Usami H. Effects of drugs on the pyrogenicity of toxic shock syndrome toxin 1 and its capacity to enhance susceptibility to the lethal effects of endotoxic shock in rabbits. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S210–S213. doi: 10.1093/clinids/11.supplement_1.s210. [DOI] [PubMed] [Google Scholar]
  14. Kaplan M. H., Chmel H., Hsieh H. C., Stephens A., Brinsko V. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis. J Clin Microbiol. 1986 Jan;23(1):83–91. doi: 10.1128/jcm.23.1.83-91.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kushnaryov V. M., MacDonald H. S., Reiser R. F., Bergdoll M. S. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S282–S288. doi: 10.1093/clinids/11.supplement_1.s282. [DOI] [PubMed] [Google Scholar]
  16. Köhler W., Gerlach D., Knöll H. Streptococcal outbreaks and erythrogenic toxin type A. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Aug;266(1-2):104–115. doi: 10.1016/s0176-6724(87)80024-x. [DOI] [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Lee P. K., Schlievert P. M. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J Clin Microbiol. 1989 Aug;27(8):1890–1892. doi: 10.1128/jcm.27.8.1890-1892.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marrack P., Blackman M., Kushnir E., Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med. 1990 Feb 1;171(2):455–464. doi: 10.1084/jem.171.2.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  21. Melish M. E., Murata S., Fukunaga C., Frogner K., Hirata S., Wong C. Endotoxin is not an essential mediator in toxic shock syndrome. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S219–S230. doi: 10.1093/clinids/11.supplement_1.s219. [DOI] [PubMed] [Google Scholar]
  22. Morlock B. A., Spero L., Johnson A. D. Mitogenic activity of staphylococcal exfoliative toxin. Infect Immun. 1980 Nov;30(2):381–384. doi: 10.1128/iai.30.2.381-384.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Norton S. D., Schlievert P. M., Novick R. P., Jenkins M. K. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. J Immunol. 1990 Mar 15;144(6):2089–2095. [PubMed] [Google Scholar]
  24. Parsonnet J., Gillis Z. A., Pier G. B. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome. J Infect Dis. 1986 Jul;154(1):55–63. doi: 10.1093/infdis/154.1.55. [DOI] [PubMed] [Google Scholar]
  25. Parsonnet J., Gillis Z. A. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1. J Infect Dis. 1988 Nov;158(5):1026–1033. doi: 10.1093/infdis/158.5.1026. [DOI] [PubMed] [Google Scholar]
  26. Parsonnet J., Gillis Z. A., Richter A. G., Pier G. B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun. 1987 May;55(5):1070–1076. doi: 10.1128/iai.55.5.1070-1076.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parsonnet J., Hickman R. K., Eardley D. D., Pier G. B. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis. 1985 Mar;151(3):514–522. doi: 10.1093/infdis/151.3.514. [DOI] [PubMed] [Google Scholar]
  28. Poindexter N. J., Schlievert P. M. Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1. J Infect Dis. 1986 Apr;153(4):772–779. doi: 10.1093/infdis/153.4.772. [DOI] [PubMed] [Google Scholar]
  29. Poindexter N. J., Schlievert P. M. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J Infect Dis. 1985 Jan;151(1):65–72. doi: 10.1093/infdis/151.1.65. [DOI] [PubMed] [Google Scholar]
  30. Rizkallah M. F., Tolaymat A., Martinez J. S., Schlievert P. M., Ayoub E. M. Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1. Am J Dis Child. 1989 Jul;143(7):848–849. doi: 10.1001/archpedi.1989.02150190098031. [DOI] [PubMed] [Google Scholar]
  31. SCHWAB J. H., WATSON D. W., CROMARTIE W. J. Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J Infect Dis. 1955 Jan-Feb;96(1):14–18. doi: 10.1093/infdis/96.1.14. [DOI] [PubMed] [Google Scholar]
  32. SCHWAB J. H., WATSON D. W., CROMARTIE W. J. Production of generalized Shwartzman reaction with group A streptococcal factors. Proc Soc Exp Biol Med. 1953 Apr;82(4):754–761. doi: 10.3181/00379727-82-20237. [DOI] [PubMed] [Google Scholar]
  33. Sato N., Goto T., Haranaka K., Satomi N., Nariuchi H., Mano-Hirano Y., Sawasaki Y. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst. 1986 Jun;76(6):1113–1121. [PubMed] [Google Scholar]
  34. Schlievert P. M. Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins. Infect Immun. 1980 Jun;28(3):876–880. doi: 10.1128/iai.28.3.876-880.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schlievert P. M., Bettin K. M., Watson D. W. Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis. 1979 Nov;140(5):676–681. doi: 10.1093/infdis/140.5.676. [DOI] [PubMed] [Google Scholar]
  36. Schlievert P. M., Bettin K. M., Watson D. W. Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun. 1977 May;16(2):673–679. doi: 10.1128/iai.16.2.673-679.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schlievert P. M., Blomster D. A. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis. 1983 Feb;147(2):236–242. doi: 10.1093/infdis/147.2.236. [DOI] [PubMed] [Google Scholar]
  38. Schlievert P. M., Schoettle D. J., Watson D. W. Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun. 1979 Sep;25(3):1075–1077. doi: 10.1128/iai.25.3.1075-1077.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  40. Schlievert P. M. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet. 1986 May 17;1(8490):1149–1150. doi: 10.1016/s0140-6736(86)91859-3. [DOI] [PubMed] [Google Scholar]
  41. Schmitt-Verhulst A. M., Guimezanes A., Boyer C., Poenie M., Tsien R., Buferne M., Hua C., Leserman L. Pleiotropic loss of activation pathways in a T-cell receptor alpha-chain deletion variant of a cytolytic T-cell clone. Nature. 1987 Feb 12;325(6105):628–631. doi: 10.1038/325628a0. [DOI] [PubMed] [Google Scholar]
  42. Stevens D. L., Tanner M. H., Winship J., Swarts R., Ries K. M., Schlievert P. M., Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989 Jul 6;321(1):1–7. doi: 10.1056/NEJM198907063210101. [DOI] [PubMed] [Google Scholar]
  43. Stone R. L., Schlievert P. M. Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis. 1987 Apr;155(4):682–689. doi: 10.1093/infdis/155.4.682. [DOI] [PubMed] [Google Scholar]
  44. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  45. WATSON D. W. Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins. J Exp Med. 1960 Feb 1;111:255–284. doi: 10.1084/jem.111.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
  47. de Azavedo J. C., Arbuthnott J. P. Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun. 1984 Nov;46(2):314–317. doi: 10.1128/iai.46.2.314-317.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES